European white paper: oropharyngeal dysphagia in head and neck cancer

TY - JOUR

T1 - European white paper: oropharyngeal dysphagia in head and neck cancer

AU - Baijens, Laura W J

AU - Walshe, Margaret

AU - Aaltonen, Leena-Maija

AU - Arens, Christoph

AU - Cordier, Reinie

AU - Cras, Patrick

AU - Crevier-Buchman, Lise

AU - Curtis, Chris

AU - Golusinski, Wojciech

AU - Govender, Roganie

AU - Eriksen, Jesper Grau

AU - Hansen, Kevin

AU - Heathcote, Kate

AU - Hosal, Sefik

AU - Klussmann, Jens Peter

AU - Leemans, C René

AU - MacCarthy, Denise

AU - Manduchi, Beatrice

AU - Marie, Jean-Paul

AU - Nouraei, Reza

AU - Parkes, Claire

AU - Pflug, Christina

AU - Pilz, Walmari

AU - Regan, Julie

AU - Rommel, Nathalie

AU - Schindler, Antonio

AU - Schols, Annemie M W J

AU - Speyer, Renee

AU - Succo, Giovanni

AU - Wessel, Irene

AU - Willemsen, Anna C H

AU - Yilmaz, Taner

AU - Clavé, Pere

AU - Hess, Markus

PY - 2021/2

Y1 - 2021/2

N2 - PURPOSE: To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the management of OD associated with HNC across Europe.METHODS: Experts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. Evidence is based on systematic reviews, consensus-based position statements, and expert opinion.RESULTS: Twenty-four sections on HNC-specific OD topics.CONCLUSION: This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Meanwhile, its management remains a challenge for European professional associations and policymakers.

AB - PURPOSE: To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the management of OD associated with HNC across Europe.METHODS: Experts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. Evidence is based on systematic reviews, consensus-based position statements, and expert opinion.RESULTS: Twenty-four sections on HNC-specific OD topics.CONCLUSION: This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Meanwhile, its management remains a challenge for European professional associations and policymakers.

U2 - 10.1007/s00405-020-06507-5

DO - 10.1007/s00405-020-06507-5

M3 - SCORING: Journal article

C2 - 33341909

VL - 278

SP - 577

EP - 616

JO - EUR ARCH OTO-RHINO-L

JF - EUR ARCH OTO-RHINO-L

SN - 0937-4477

IS - 2

ER -